Fact CheckerSign in

NCT06337279Completed

Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk

The Clinical Value of Systemic Oxidative Stress Score in Predicting Long-term Survival and Recurrence Risk in Gastric Cancer: A Multicenter Real-world Cohort Study

Source: ClinicalTrials.gov · Last updated 29 Mar 2024

Brief summary (registry, in English)

The Systemic Oxidative Stress Score (SOSS) , a comprehensive score reflecting the oxidative stress conditions in the microenvironment, can independently and effectively predict tumor burden and long-term prognosis in GC patients. Nomograms based on SOSS provide a potential and promising model for risk stratification and guiding the implementation of treatment decisions.

Status (registry)
Completed
Study type
Observational
Enrollment
3820 (actual)
First submitted
22 Mar 2024
Start date
10 Dec 2022
Primary completion date
20 Aug 2023
Lead sponsor
Fujian Medical University
NCT number
NCT06337279

What you commit to

  • Study type: Observational
  • Participants enrolled: 3820
  • From 10 Dec 2022 to the primary completion date, 20 Aug 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • 1\) gastroscopic histopathological diagnosis of non-adenocarcinoma, 2) gastric stump cancer, 3) neoadjuvant chemotherapy, 4) other malignant diseases besides GC, 5) incomplete medical records, and 6) patients with GC lost to follow-up.

Who the study is looking for

  • 1\) gastroscopic histopathological diagnosis of gastric adenocarcinoma; 2) radical gastrectomy for GC; 3) preoperative examination of oxidative indicators including Fbg, CHOL, ALB, TBIL, DBIL, and CR within seven days before surgery; and 4) the tumor did not invade neighboring organs or had no distant metastasis.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fujian Medical University Union Hospital
Coordinator of this site? Confirm its status
FuzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.